Yaz Birth Control Controversy: Pharmaceutical Profits, Unnecessary Risks, And The Gendered Distribution Of Family Planning

  The current Yaz birth control controversy illustrates the continued tension between what pharmaceutical companies and the doctors that they pay claim is safe for consumption, and contrary scientific evidence. Natasha Singer of the New York Times is reporting that Yaz, a birth control pill manufactured and marketed by Bayer, is under fire as an inappropriately advertised, improperly made, more dangerous pill.  Two new studies out of Denmark and Holland and published in the British Medical J...

View the entire post by clicking here